2012 annual financial data
Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) 2012 Operating margin
Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) 2012 operating margin…
Direct answer
Operating margin was -42.98%.
Operating income was -21,151,000 USD and net income was -14,853,000 USD.
Operating cash flow was -16,254,000 USD.
Get free Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 49,216,000 USD
- Operating income
- -21,151,000 USD
- Net income
- -14,853,000 USD
- Operating cash flow
- -16,254,000 USD
Explore related company data
View all 2012 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) financial years